摘要 |
The invention describes novel compounds of the formula I which are biologically active as ligands of integrin alphavbeta3in which X, Y, Z, R<1>, R<2>, R<4 >and R<5 >are as defined in claim 1, and their physiologically acceptable salts and solvates. |